IRCT20190419043318N1
Recruiting
Phase 3
Evaluation of therapeutic and immunologic effects of Crocina in knee osteoarthritis patients: A randomized double-blind placebo-controlled trial
Bojnourd University of Medical Sciences0 sites60 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- osteoarthritis.
- Sponsor
- Bojnourd University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) aged over 40 years
- •2\) Primary osteoarthritis
- •3\) Pain in more than half the days of the previous month during one of the following activities: walking, climbing and stairs, standing up or sleeping on the bed or mattress during the night
- •4\) Radiographic evidence of tibiafemoral or patellofemoral osteoarthritis
- •5\) A score of 40 from the WOMAC scale as a base
- •6\) No intra\-articular injection of hyaluronic acid / glucocorticoid over the last six months
- •7\) The lack of a positive pregnancy test or pregnancy program during the study
Exclusion Criteria
- •1\) intolerance to the drug
- •2\) Do not take medicine properly
- •3\) Serious medical conditions that the patient can not regularly attend periodic visits include severe cardiovascular disease such as angina or heart attack, severe hypertension, recent stroke, insulin dependent diabetes, psychiatric disorders, kidney disease, liver disease, active concen , And anemia
- •4\) history of liver disease
- •5\) Inability to walk without a cane
- •6\) A history of autoimmune diseases such as rheumatoid arthritis
- •7\) Secondary osteoarthritis, for example, following a trauma
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40
Active, not recruiting
Phase 1
A study to investigate the clinical and immunological effects on field cancerization in patients treated with PD-1 inhibition for advanced or metastatic cutaneous squamous cell carcinomaadvanced or metastatic cutaneous squamous cell carcinomaMedDRA version: 24.1Level: LLTClassification code 10085908Term: Cutaneous squamous cell carcinomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-006372-17-DEMuehlenkreiskliniken AoeR20
Completed
Phase 2
Analysis of efficacy and immunomodulatory activity of lenalidomide alone in relapse and refractory multiple myelomaplasma cell myelomaJPRN-UMIN000009927Hematology, Respiratory Medicine and Oncology,Faculty of Medicine, Saga University33
Completed
Not Applicable
Clinical and immunological analysis on the effect of LEM in the adoptive immunotherapy using autologous activated lymphocytes in patients with incurable cancerIncurable cancerJPRN-UMIN000012283Kawasaki Medical School20
Recruiting
Phase 2
Efficacy stem cells in improving the symptoms of patients with lupusIRCT20130812014333N182Kermanshah University of Medical Sciences20